Carmen Coxon

795 total citations
26 papers, 566 citations indexed

About

Carmen Coxon is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Carmen Coxon has authored 26 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Hematology and 5 papers in Immunology. Recurrent topics in Carmen Coxon's work include Platelet Disorders and Treatments (9 papers), Hemophilia Treatment and Research (6 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Carmen Coxon is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Hemophilia Treatment and Research (6 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Carmen Coxon collaborates with scholars based in United Kingdom, United States and Canada. Carmen Coxon's co-authors include Katrina A. Bicknell, Gavin Brooks, Mitchell J. Geer, Yotis A. Senis, Jonathan M. Gibbins, Chris I. Jones, R. Duncan Campbell, Katherine L. Tucker, Ronak Tilvawala and Denisa D. Wagner and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Carmen Coxon

24 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Coxon United Kingdom 12 321 141 95 92 71 26 566
Jean-Marie Xuereb France 12 279 0.9× 68 0.5× 70 0.7× 125 1.4× 60 0.8× 17 506
Dorothea M. Heuberger Switzerland 9 122 0.4× 60 0.4× 37 0.4× 121 1.3× 46 0.6× 18 440
Xin Deng China 13 168 0.5× 56 0.4× 21 0.2× 41 0.4× 87 1.2× 26 421
Felix Zhou United States 8 451 1.4× 127 0.9× 52 0.5× 23 0.3× 67 0.9× 24 652
Shumei Ren United States 11 266 0.8× 187 1.3× 29 0.3× 19 0.2× 266 3.7× 14 595
Di Xiang China 15 284 0.9× 102 0.7× 88 0.9× 20 0.2× 52 0.7× 27 559
Jiaochan Han China 11 419 1.3× 219 1.6× 8 0.1× 60 0.7× 44 0.6× 16 683
Melanie Hofmann Germany 9 162 0.5× 124 0.9× 53 0.6× 10 0.1× 42 0.6× 16 375

Countries citing papers authored by Carmen Coxon

Since Specialization
Citations

This map shows the geographic impact of Carmen Coxon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Coxon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Coxon more than expected).

Fields of papers citing papers by Carmen Coxon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Coxon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Coxon. The network helps show where Carmen Coxon may publish in the future.

Co-authorship network of co-authors of Carmen Coxon

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Coxon. A scholar is included among the top collaborators of Carmen Coxon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Coxon. Carmen Coxon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coxon, Carmen, Elizabeth Bell, Evelien M. Adriaenssens, et al.. (2025). Interpretation guidance for MHRA regulatory considerations for phage therapeutic products. Microbiology. 171(11).
2.
Moon, Kyung D., Carmen Coxon, Christine Årdal, et al.. (2025). Considerations and perspectives on phage therapy from the transatlantic taskforce on antimicrobial resistance. Nature Communications. 16(1). 10883–10883.
3.
Davulcu, Omar, et al.. (2024). Cryoem Structures and Conformational Landscapes of Activated Blood Coagulation Factor VIII and the Intrinsic Tenase Complex. Blood. 144(Supplement 1). 428–428. 1 indexed citations
4.
Cowper, Ben, Omar Davulcu, Pete Lollar, et al.. (2024). Structural basis for inhibition of coagulation factor VIII reveals a shared antigenic hotspot on the C1 domain. Journal of Thrombosis and Haemostasis. 22(9). 2449–2459. 1 indexed citations
5.
Coxon, Carmen, et al.. (2024). Limitations of current techniques in clinical antimicrobial resistance diagnosis: examples and future prospects. SHILAP Revista de lepidopterología. 2(1). 16–16. 24 indexed citations
6.
Davulcu, Omar, et al.. (2023). Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor. Blood. 142(2). 197–201. 3 indexed citations
7.
Doering, Christopher B., et al.. (2023). Cryo-EM Structure of Coagulation Factor VIII Bound to a Patient-Derived Anti-A2 Domain Antibody Inhibitor. Blood. 142(Supplement 1). 2598–2598. 2 indexed citations
8.
Arsiccio, Andrea, Clive Metcalfe, Roberto Pisano, S. Raut, & Carmen Coxon. (2022). A proximity-based in silico approach to identify redox-labile disulfide bonds: The example of FVIII. PLoS ONE. 17(2). e0262409–e0262409. 1 indexed citations
10.
Coxon, Carmen, Colin Longstaff, & Chris Burns. (2019). Applying the science of measurement to biology: Why bother?. PLoS Biology. 17(6). e3000338–e3000338. 14 indexed citations
11.
Panckeri, Karen, Lacramioara Ivanciu, Rodney M. Camire, et al.. (2019). Microfluidic hemophilia models using blood from healthy donors. Research and Practice in Thrombosis and Haemostasis. 4(1). 54–63. 5 indexed citations
12.
Metcalfe, Clive, et al.. (2016). Thioredoxin Inhibitors Attenuate Platelet Function and Thrombus Formation. PLoS ONE. 11(10). e0163006–e0163006. 18 indexed citations
13.
Tannetta, Dionne, Kathryn Hunt, Chris I. Jones, et al.. (2015). Syncytiotrophoblast Extracellular Vesicles from Pre-Eclampsia Placentas Differentially Affect Platelet Function. PLoS ONE. 10(11). e0142538–e0142538. 59 indexed citations
14.
Taylor, Lewis, Sridhar R. Vasudevan, Chris I. Jones, et al.. (2014). Discovery of Novel GPVI Receptor Antagonists by Structure-Based Repurposing. PLoS ONE. 9(6). e101209–e101209. 23 indexed citations
15.
Coxon, Carmen, et al.. (2012). An Investigation of Hierachical Protein Recruitment to the Inhibitory Platelet Receptor, G6B-b. PLoS ONE. 7(11). e49543–e49543. 18 indexed citations
16.
Coxon, Carmen, Alexander M. Lewis, Sridhar R. Vasudevan, et al.. (2011). NAADP regulates human platelet function. Biochemical Journal. 441(1). 435–442. 11 indexed citations
17.
Coxon, Carmen, et al.. (2009). Over Expression of Plk1 Does Not Induce Cell Division in Rat Cardiac Myocytes In Vitro. PLoS ONE. 4(8). e6752–e6752. 3 indexed citations
18.
Bicknell, Katrina A., Carmen Coxon, & Gavin Brooks. (2007). Can the cardiomyocyte cell cycle be reprogrammed?. Journal of Molecular and Cellular Cardiology. 42(4). 706–721. 68 indexed citations
19.
Bicknell, Katrina A., Carmen Coxon, & Gavin Brooks. (2004). Forced expression of the cyclin B1–CDC2 complex induces proliferation in adult rat cardiomyocytes. Biochemical Journal. 382(2). 411–416. 69 indexed citations
20.
Bicknell, Katrina A., et al.. (2003). Inhibition of E2F Abrogates the Development of Cardiac Myocyte Hypertrophy. Journal of Biological Chemistry. 278(24). 21388–21394. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026